These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34793289)

  • 1. Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
    van den Berge M; Faiz A
    Am J Respir Crit Care Med; 2022 Jan; 205(2):139-140. PubMed ID: 34793289
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating miRNAs as diagnostic tool for discrimination of respiratory disease: Asthma, asthma-chronic obstructive pulmonary disease (COPD) overlap and COPD.
    Rodrigo-Muñoz JM; Rial MJ; Sastre B; Cañas JA; Mahíllo-Fernández I; Quirce S; Sastre J; Cosío BG; Del Pozo V
    Allergy; 2019 Dec; 74(12):2491-2494. PubMed ID: 31125431
    [No Abstract]   [Full Text] [Related]  

  • 3. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.
    Barnes PJ
    Am J Respir Crit Care Med; 2006 Aug; 174(3):240-3; discussion 243-4. PubMed ID: 16864717
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcriptomic Signature of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Whole Blood.
    Saferali A; Yun JH; Lee S; Chase RP; Bowler RP; Castaldi PJ; Hersh CP
    Am J Respir Cell Mol Biol; 2021 Feb; 64(2):268-271. PubMed ID: 33522883
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma and . . . what is the link?
    Kabesch M
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):393-4. PubMed ID: 19697447
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease.
    Zervou MI; Tzortzaki EG; Makris D; Gaga M; Zervas E; Economidou E; Tsoumakidou M; Tzanakis N; Milic-Emili J; Siafakas NM
    Eur Respir J; 2006 Sep; 28(3):472-8. PubMed ID: 16707512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple dimensions of airways disease: targeting treatment to clinical phenotypes.
    Shirtcliffe P; Weatherall M; Travers J; Beasley R
    Curr Opin Pulm Med; 2011 Mar; 17(2):72-8. PubMed ID: 21150622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asthma-COPD overlap syndrome].
    Odler B; Müller V
    Orv Hetil; 2016 Aug; 157(33):1304-13. PubMed ID: 27523313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Plasma Levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in Patients with Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS).
    Bersimbaev R; Aripova A; Bulgakova O; Kussainova А; Akparova A; Izzotti A
    Microrna; 2021; 10(2):130-138. PubMed ID: 34151771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Dutch hypothesis.
    Postma DS; Weiss ST; van den Berge M; Kerstjens HA; Koppelman GH
    J Allergy Clin Immunol; 2015 Sep; 136(3):521-9. PubMed ID: 26343936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.
    Lacedonia D; Palladino GP; Foschino-Barbaro MP; Scioscia G; Carpagnano GE
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1811-1817. PubMed ID: 28694694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases.
    Pattarayan D; Thimmulappa RK; Ravikumar V; Rajasekaran S
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):480-492. PubMed ID: 27677501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases.
    Marčetić D; Samaržija M; Vukić Dugac A; Knežević J
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating vitamin D transcriptomics to clinical evidence: Analysis of data in asthma and chronic obstructive pulmonary disease, followed by clinical data meta-analysis.
    Malliaraki N; Lakiotaki K; Vamvoukaki R; Notas G; Tsamardinos I; Kampa M; Castanas E
    J Steroid Biochem Mol Biol; 2020 Mar; 197():105505. PubMed ID: 31669573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic obstructive pulmonary diseases and asthma in children: diagnostic and therapeutic strategies].
    Derelle J
    Arch Pediatr; 2004 Jun; 11 Suppl 2():103s-106s. PubMed ID: 15301806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0.
    Groth EE; Weber M; Bahmer T; Pedersen F; Kirsten A; Börnigen D; Rabe KF; Watz H; Ammerpohl O; Goldmann T
    Respir Res; 2020 Oct; 21(1):274. PubMed ID: 33076907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in the assessment and management of airways diseases.
    Taylor DR; Pavord ID
    Postgrad Med J; 2008 Dec; 84(998):628-34; quiz 633. PubMed ID: 19201936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.